Company

History

Apop Imaging Pty Ltd was registered as a company in October 2016 (ACN 615 441 113) by founding director and medical researcher Dr Peter Wookey. We named our company Apop Imaging after the major form of Programmed Cell Death (PCD) Apoptosis.

Dr Wookey discovered and developed the proprietary calcitonin receptor antibodies and protected the Intellectual Property in two patents. The IP is fully owned by Apop Imaging.

Management

Chief Executive Officer
Dr Barbara Meurer

Chief Scientific Officer
Dr Peter Wookey

Chief Financial Officer
Roger McPherson

Board

Independent Chair
Zoe Attwood

Executive Director
Dr Peter Wookey

Non-executive Director
Trevor Tappenden